Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization

A Review from a Malaysian Perspective

Mohd Rizal Abdul Manaf, Naren Kumar Surendra, Abdul Halim Abdul Gafor, Lai Seong Hooi, Sunita Bavanandan

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.

Original languageEnglish
Article number5819629
JournalInternational Journal of Nephrology
Volume2017
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Utilization Review
Peritoneal Dialysis
Dialysis
Economics
Health
Renal Dialysis
Malaysia
Population
Chronic Kidney Failure
Government Financing
Transplants
Kidney
Private Sector
Health Expenditures
Health Policy
Cost-Benefit Analysis
Tissue Donors
Costs and Cost Analysis

ASJC Scopus subject areas

  • Nephrology

Cite this

Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization : A Review from a Malaysian Perspective. / Abdul Manaf, Mohd Rizal; Surendra, Naren Kumar; Abdul Gafor, Abdul Halim; Hooi, Lai Seong; Bavanandan, Sunita.

In: International Journal of Nephrology, Vol. 2017, 5819629, 01.01.2017.

Research output: Contribution to journalReview article

@article{690e1dfadd5d40359d3650b78e3a6a4c,
title = "Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization: A Review from a Malaysian Perspective",
abstract = "End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.",
author = "{Abdul Manaf}, {Mohd Rizal} and Surendra, {Naren Kumar} and {Abdul Gafor}, {Abdul Halim} and Hooi, {Lai Seong} and Sunita Bavanandan",
year = "2017",
month = "1",
day = "1",
doi = "10.1155/2017/5819629",
language = "English",
volume = "2017",
journal = "International Journal of Nephrology",
issn = "2090-214X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization

T2 - A Review from a Malaysian Perspective

AU - Abdul Manaf, Mohd Rizal

AU - Surendra, Naren Kumar

AU - Abdul Gafor, Abdul Halim

AU - Hooi, Lai Seong

AU - Bavanandan, Sunita

PY - 2017/1/1

Y1 - 2017/1/1

N2 - End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.

AB - End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.

UR - http://www.scopus.com/inward/record.url?scp=85042270230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042270230&partnerID=8YFLogxK

U2 - 10.1155/2017/5819629

DO - 10.1155/2017/5819629

M3 - Review article

VL - 2017

JO - International Journal of Nephrology

JF - International Journal of Nephrology

SN - 2090-214X

M1 - 5819629

ER -